Mans, D R <br/><br/>
Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas.  [electronic resource] 

 -  Tumori   
 - 458-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0300-8916 
<br/><br/><label>Standard No.: </label>10.1177/030089160008600605  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--drug therapy<br/>Topotecan--administration & dosage<br/>Treatment Failure